These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12394224)

  • 41. One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer.
    Mesquita MA; Lorena SL; Almeida JR; Montes CG; Guerrazzi F; Campos LT; Zeitune JM
    World J Gastroenterol; 2005 Jun; 11(23):3566-9. PubMed ID: 15962376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ranitidine bismuth citrate with either clarithromycin 1 g/day or 1.5 g/day is equally effective in the eradication of H. pylori and healing of duodenal ulcer.
    Dobrilla G; Di Matteo G; Dodero M; Fratton A; Iaquinto G; Loriga P; Marchi S; Marzio L; Muratori R; Pacini D; Saggioro A; Savarino V; Spinelli P; Zamboni G; Fina P; Tosatto R; Olivieri A
    Aliment Pharmacol Ther; 1998 Jan; 12(1):63-8. PubMed ID: 9692703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori.
    Axon AT; Ireland A; Smith MJ; Rooprams PD
    Aliment Pharmacol Ther; 1997 Feb; 11(1):81-7. PubMed ID: 9042977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
    Thong-Ngam D; Tangkijvanich P; Treeprasertsuk S; Wisedopas N; Kullavanijaya P
    J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole.
    Janssen MJ; Van Oijen AH; Verbeek AL; Jansen JB; De Boer WA
    Aliment Pharmacol Ther; 2001 May; 15(5):613-24. PubMed ID: 11328254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
    Van der Wouden EJ; Thijs JC; Zwet AA; Kooy A; Kleibeuker JH
    Aliment Pharmacol Ther; 1999 Mar; 13(3):297-302. PubMed ID: 10102961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection.
    Tursi A; Brandimarte G; Giorgetti G; Modeo ME; Gigliobianco A
    Hepatogastroenterology; 2002; 49(46):1006-9. PubMed ID: 12143188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori.
    Smoot DT; Hinds T; Ashktorab H; Jagtap J; Kim KS; Scott VF
    Am J Gastroenterol; 1999 Apr; 94(4):955-8. PubMed ID: 10201463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo.
    Mégraud F; Roberts P; Williamson R
    Helicobacter; 2000 Dec; 5(4):222-6. PubMed ID: 11179987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments.
    Neri M; Milano A; Laterza F; Di Bonaventura G; Piccolomini R; Caldarella MP; Balatsinou C; Lapenna D; Cuccurullo F
    Aliment Pharmacol Ther; 2003 Oct; 18(8):821-7. PubMed ID: 14535876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
    Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB
    Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Seven-day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride.
    Williams MP; Hamilton MR; Sercombe JC; Pounder RE
    Aliment Pharmacol Ther; 1997 Aug; 11(4):705-10. PubMed ID: 9305479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparative study of the eradication of Helicobacter pylori: ranitidine bismuth citrate versus omeprazole plus two antibiotics for seven days].
    Bujanda L; Sánchez A; Iriondo C; Santos A; Cosme A; Muñoz C
    An Med Interna; 2001 Jul; 18(7):361-3. PubMed ID: 11534420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of Helicobacter pylori eradication therapies: a single centre observational study.
    Beales IL
    BMC Gastroenterol; 2001; 1():7. PubMed ID: 11545677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
    Vakil N; Cutler A
    Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Cianci R; Gasbarrini A; Pirozzi G; Gasbarrini G
    Hepatogastroenterology; 2000; 47(34):1176-9. PubMed ID: 11020908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies.
    Van Oijen AH; Verbeek AL; Jansen JB; De Boer WA
    Aliment Pharmacol Ther; 2000 Aug; 14(8):991-9. PubMed ID: 10930892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
    Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.